Jun Ota

1.4k citations

47 papers · 1.1k indexed · h-index 19

Impact in

Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Screening and Detection
- Cancer Treatment and Pharmacology
Cancer Research top 10%
- Breast Cancer Treatment Studies

Papers in ⓘ

Oncology 15
- Cancer Treatment and Pharmacology 4
- Colorectal Cancer Treatments and Studies 4
Hematology 6
- Acute Myeloid Leukemia Research 4

Co-authors: Hiroyuki Mano (15 shared papers)Yoshihiro Yamashita (14 shared papers)Koji Koinuma (13 shared papers)Young Lim Choi (11 shared papers)Tomoaki Wada (8 shared papers)Ruri Ohki (7 shared papers)Akira Shirakawa (6 shared papers)Shuichi Ueno (8 shared papers)
Journals: Biochemical and Biophysical Research Communications (4 papers)British Journal of Haematology (2 papers)Leukemia (2 papers)Cancer Science (2 papers)Oncogene (2 papers)
Partner nations: Japan United States United Kingdom

In The Last Decade

Jun Ota

47 papers receiving 1.0k citations

Peers

Countries citing papers authored by Jun Ota

Since Specialization

Citations

This map shows the geographic impact of Jun Ota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Ota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Ota more than expected).

Fields of papers citing papers by Jun Ota

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Ota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Ota. The network helps show where Jun Ota may publish in the future.

Co-authors

The 25 scholars most cited alongside Jun Ota, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jun Ota Line = papers co-authored together Jun Ota links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Mutations of BRAF are associated with extensive hMLH1 promoter methylation in sporadic colorectal carcinomas International Journal of Cancer ·Koji Koinuma, Kazuhisa Shitoh, Yasuyuki Miyakura, Taiji Furukawa, Yoshihiro Yamashita, Jun Ota, Ruri Ohki, Young Lim Choi, Tomoaki Wada, Fumio Konishi, Hideo Nagai, Hiroyuki Mano	2003	105
2	Tumor Growth Rate and Prognosis of Breast Cancer Mainly Detected by Mass Screening Japanese Journal of Cancer Research ·Tetsuo Kuroishi, Suketami Tominaga, Tadaoki Morimoto, Hideya Tashiro, Sueyoshi Itoh, Hiromu Watanabe, Mamoru Fukuda, Jun Ota, Toshio Horino, Tsunehiro Ishida, Takao Yokoe, Kohji Enomoto, Yoshitomo Kashiki, Masami Ogita	1990	76
3	Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells Cancer Science ·Madoka Ishikawa, Koji Yoshida, Yoshihiro Yamashita, Jun Ota, Shuji Takada, Hiroyuki Kisanuki, Koji Koinuma, Young Lim Choi, Ruri Kaneda, Toshiyasu Iwao, Kiichi Tamada, Kentaro Sugano, Hiroyuki Mano	2005	73
4	A phase II study of S-1 in patients with metastatic breast cancer — A Japanese trial by the S-1 cooperative study group, breast cancer working group Breast Cancer ·Toshiaki Saeki, Shigemitsu Takashima, Muneaki Sano, N Horikoshi, Shigeto Miura, Satoru Shimizu, Ken Morimoto, Morihiko Kimura, Hideaki Aoyama, Jun Ota, Shinzaburo Noguchi, T Taguchi	2004	69
5	[A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)]. PubMed ·Masayoshi Mai, Yuh Sakata, Rihito Kanamaru, M Kurihara, M Suminaga, Jun Ota, Naoki Hirabayashi, T Taguchi, H Furue	1999	68
6	Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells Oncogene ·Ken Ohmine, Jun Ota, Masuzu Ueda, Shuichi Ueno, Koji Yoshida, Yoshihiro Yamashita, Keita Kirito, Shigehiko Imagawa, Yuichi Nakamura, Kenji Saito, Miyuki Akutsu, Kinuko Mitani, Yasuhiko Kano, Norio Komatsu, Keiya Ozawa, Hiroyuki Mano	2001	67
7	DNA microarray analysis of stage progression mechanism in myelodysplastic syndrome British Journal of Haematology ·Masuzu Ueda, Jun Ota, Yoshihiro Yamashita, Young Lim Choi, Ruri Ohki, Tomoaki Wada, Koji Koinuma, Yasuhiko Kano, Keiya Ozawa, Hiroyuki Mano	2003	47
8	Proteomic analysis of hematopoietic stem cell-like fractions in leukemic disorders Oncogene ·Jun Ota, Yoshihiro Yamashita, Katsuya Okawa, Hiroyuki Kisanuki, Shin‐ichiro Fujiwara, Madoka Ishikawa, Young Lim Choi, Shuichi Ueno, Ruri Ohki, Koji Koinuma, Tomoaki Wada, Duane A. Compton, Toshihiko Kadoya, Hiroyuki Mano	2003	43
9	High-Power Yb-Doped Double-Clad Fiber Laser Directly Operating at 1178 nm Japanese Journal of Applied Physics ·Jun Ota, Akira Shirakawa, Ken-ichi Ueda Ken-ichi Ueda	2006	35
10	Sak Serine-Threonine Kinase Acts as an Effector of Tec Tyrosine Kinase Journal of Biological Chemistry ·Yoshihiro Yamashita, Sachiko Kajigaya, Koji Yoshida, Shuichi Ueno, Jun Ota, Ken Ohmine, Masuzu Ueda, Akira Miyazato, Ken‐ichi Ohya, Toshio Kitamura, Keiya Ozawa, Hiroyuki Mano	2001	34
11	Large-mode-area erbium-ytterbium-doped photonic-crystal fiber amplifier for high-energy femtosecond pulses at 1.55 �m Optics Express ·Akira Shirakawa, Jun Ota, Mitsuru Musha, Kenichi Nakagawa, Ken‐ichi Ueda, Jacob Riis Folkenberg, Jes Broeng	2005	32
12	Mass Screening for Breast Cancer: Comparison of the Clinical Stages and Prognosis of Breast Cancer Detected by Mass Screening and in Out‐patient Clinics Japanese Journal of Cancer Research ·Jun Ota, Toshio Horino, T Taguchi, Tsunehiro Ishida, M Izuo, Masami Ogita, Rikiya Abe, Hiromu Watanabe, Tadaoki Morimoto, Sueyoshi Itoh, Hideya Tashiro, Koichi Yoshida, Kazuyoshi Honda, Michizou Sasakawa, Kohji Enomoto, Yoshitomo Kashiki, C Kido, Tetsuo Kuroishi, Suketami Tominaga	1989	30
13	DNA microarray analysis of in vivo progression mechanism of heart failure Biochemical and Biophysical Research Communications ·Shuichi Ueno, Ruri Ohki, Toru Hashimoto, Toshihiro Takizawa, Koichi Takeuchi, Yoshihiro Yamashita, Jun Ota, Young Lim Choi, Tomoaki Wada, Koji Koinuma, Keiji Yamamoto, Uichi Ikeda, Kazuyuki Shimada, Hiroyuki Mano	2003	23
14	Screening of genes specifically activated in the pancreatic juice ductal cells from the patients with pancreatic ductal carcinoma Cancer Science ·Koji Yoshida, Shuichi Ueno, Toshiyasu Iwao, Souichirou Yamasaki, Akira Tsuchida, Ken Ohmine, Ruri Ohki, Young Lim Choi, Koji Koinuma, Tomoaki Wada, Jun Ota, Yoshihiro Yamashita, Kazuaki Chayama, Kazuhiro Sato, Hiroyuki Mano	2003	23
15	Nucleotide sequence and embryonic expression of quail and duck Sox9 genes General and Comparative Endocrinology ·Shuji Takada, Jun Ota, Norio Kansaku, Hideji Yamashita, Tokukazu IZUMI, Madoka Ishikawa, Tomoaki Wada, Ruri Kaneda, Young Lim Choi, Koji Koinuma, Shin‐ichiro Fujiwara, Hirotaka Aoki, Hiroyuki Kisanuki, Yoshihiro Yamashita, Hiroyuki Mano	2005	21
16	Middle Ear Myoclonus Cured by Selective Tenotomy of the Tensor Tympani Otology & Neurotology ·Hiroshi Hidaka, Youhei Honkura, Jun Ota, Shigeki Gorai, Tetsuaki Kawase, Toshimitsu Kobayashi	2013	21
17	Association of CrkL with STAT5 in Hematopoietic Cells Stimulated by Granulocyte–Macrophage Colony-Stimulating Factor or Erythropoietin Biochemical and Biophysical Research Communications ·Jun Ota, Fumihiko Kimura, Ken Sato, Naoki Wakimoto, Yukitsugu Nakamura, Naokazu Nagata, Shinya Suzu, Muneo Yamada, Seiichi Shimamura, Kazuo Motoyoshi	1998	20
18	DNA microarray analysis of hematopoietic stem cell-like fractions from individuals with the M2 subtype of acute myeloid leukemia Leukemia ·Yasuo Oshima, M Ueda, Yumi Yamashita, Young-Lim Choi, Jun Ota, Shuichi Ueno, Ruri Ohki, Koji Koinuma, Tomoaki Wada, K Ozawa, Akio Fujimura, Hiroyuki Mano	2003	19
19	DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3−CD56+ fractions Leukemia ·Young-Lim Choi, Hideki Makishima, Jun Ohashi, Yumi Yamashita, Ruri Ohki, Koji Koinuma, Jun Ota, Yasushi Isobe, Fumihiro Ishida, Kazuo Oshimi, Hiroyuki Mano	2004	19
20	New treatment for invasive fungal sinusitis: Three cases of chronic invasive fungal sinusitis treated with surgery and voriconazole Auris Nasus Larynx ·Kazuhiro Nakaya, Takeshi Oshima, Takayuki Kudo, Iori Aoyagi, Yukio Katori, Jun Ota, Hiroshi Hidaka, Kiyoshi Oda, Toshimitsu Kobayashi	2009	17

About Jun Ota

Jun Ota is a scholar working on Oncology, Hematology, Cancer Research, Genetics and Immunology, having authored 47 papers that have together received 1.1k indexed citations. Recurring topics across this work include Photonic Crystal and Fiber Optics (6 papers), Advanced Fiber Laser Technologies (6 papers), Cancer Treatment and Pharmacology (4 papers), Acute Myeloid Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Advanced Fiber Optic Sensors (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Oncology (406 citations), Cancer Research (170 citations), Hematology (117 citations), Pathology and Forensic Medicine (187 citations) and Genetics (81 citations). Jun Ota has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hiroyuki Mano, Yoshihiro Yamashita, Koji Koinuma, Young Lim Choi, Tomoaki Wada, Ruri Ohki, Akira Shirakawa, Shuichi Ueno, T Taguchi and Koji Yoshida. Their work appears in journals such as Biochemical and Biophysical Research Communications, British Journal of Haematology, Leukemia, Cancer Science and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact